Advertisement

Topics

BioGenes - Gesellschaft für Biopolymere mbH Company Profile

14:54 EDT 25th September 2017 | BioPortfolio

BioGenes is a world-wide acting full-service supplier of protein analysis services, customised polyclonal and monoclonal antibodies as well as immunoassays with strong commitment to quality and service.

BioGenes supports customers with a whole range of GMP-compliant analytical services starting from feasibility assessments to complete immunoassay development, validation, manufacturing, and implementation. BioGenes’ repertoire comprises the design of sandwich and competitive assays for the qualitative and quantitative determination of antigens or antibodies, and the development, validation and production of generic or process-specific Host Cell Protein ELISAs for quality control.

BioGenes develops monoclonal antibodies against all kinds of antigens (peptides, soluble proteins, membrane proteins, phosphorylated antigens, small organic molecules like haptens, oligo- and polysaccharides as well as highly toxic substances) including monoclonal antibodies that distinguish modified proteins and peptides from non-modified (e.g. phosphorylation, methylation etc.) as well as anti-idiotypic antibodies. For universities, institutes and industrial research BioGenes offers affordable routine polyclonal and monoclonal antibody development.

Successful long-term alliances with biotech and pharmaceutical companies prove that BioGenes is the partner of choice in the fields of protein analysis. BioGenes is certified to meet the international the international requirements and regularities of quality assurance and animal welfare.

Location

Köpenicker Straße 325
Berlin
D-12555
Germany

Contact

Phone: 49 (0)30 65762396
Fax: 49 (0)30 65762397
Email: kathrin.guenther@biogenes.de


News Articles [42 Associated News Articles listed on BioPortfolio]

BioGenes Celebrates 25 Years of Excellence in Quality Control of Biotherapeutics

Berlin, Germany, July 25, 2017 / B3C newswire / -- BioGenes GmbH, specializing in ELISA development and production, is celebrating its 25-year anniversary. In 1992 the scientists Dr. Alexander K...

Anthrax: A hidden threat to wildlife in the tropics

(Max-Planck-Gesellschaft) Researchers illuminate the epidemiology of a cryptic pathogen.

Tracking the mechanisms of artery formation

(Max-Planck-Gesellschaft) The Notch signal pathway could be the basis for new therapies for cardiovascular diseases.

Epigenetics between the generations

(Max-Planck-Gesellschaft) Max Planck researchers prove that we inherit more than just genes.

Mit Enzymen Kosten sparen und die Umwelt schonen

Der Cluster Biopolymere/Biowerkstoffe ist einer von fünf Sieger-Clustern des Wettbewerbs BioIndustrie 2021 und wurde durch das Bundesministerium für Bildung und Forschung (BMBF) gefördert. Das Fors...

BB Biotech: Gesundheitsdebatte in den USA bringt Unsicherheiten

BB Biotech hat am Freitag Quartalszahlen vorgelegt. Die Gesellschaft, die sich auf Beteiligungen im Biotechsektor spezialisiert hat, meldet einen Anstieg des inneren Wertes auf Schweizer-Franken-Ba...

Mutation speeds up sperm of zebra finches

(Max-Planck-Gesellschaft) Gene inversion gives reproductive advantage to zebra finches.

Mologen: Versicherer steigt groß ein - wie reagiert die Aktie?

Liebe Leser, wie kürzlich bekannt wurde, hat die Signal Krankenversicherung einen nicht unwesentlichen Teil am Stammkapital der Gesellschaft Mologen erworben. Wie aus einer Stimmrechtsmeldung hervo.....

Drugs and Medications [0 Results]

None

Clinical Trials [4 Associated Clinical Trials listed on BioPortfolio]

A Study of the Current Medical Practice and Outcomes in the Treatment of Type 2 Diabetes Mellitus in an Office Setting (MK-0431-199)

The purpose of this study is to collect information of the risk profile of patients with type 2 diabetes mellitus, their treatment concerning meeting the guidelines for treatment of diabet...

Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)

The OMS/DES study is a multinational European Trial for Children with the Opsoclonus Myoclonus Syndrome / Dancing Eye Syndrome. This trial brought on the way by specialists of the EPNS (E...

Ziprasidone for Severe Conduct and Other Disruptive Behavior Disorders

To investigate and compare the efficacy, safety and tolerability of ziprasidone versus placebo in the treatment of conduct disorder (CD), oppositional defiant disorder (ODD) and disruptive...

Effects of Empagliflozin Plus Linagliptin vs Metformin Plus Insulin Glargin on Renal and Vascular Changes in Type 2 Diabetes

Diabetes mellitus is a wide-spread disease accompanied by strongly increased morbidity and mortality due to micro- and macrovascular complications. However, in studies with patients suffer...

Companies [18 Associated Companies listed on BioPortfolio]

BioGenes - Gesellschaft für Biopolymere mbH

BioGenes is a world-wide acting full-service supplier of protein analysis services, customised polyclonal and monoclonal antibodies as well as immunoassays with strong commitment to quality and servic...

ICHTHYOL-GESELLSCHAFT

ICHTHYOL-GESELLSCHAFT, our independent, family-run pharmaceutical company became one of the most important suppliers of therapeutics in dermatology and orthopedics due to active ingredients of high gr...

Gesellschaft für Toxikologie (GT)

NIL

Gesellschaft Deutscher Chemiker

Nil

Fraunhofer-Gesellschaft

The Fraunhofer-Gesellschaft undertakes applied research of direct utility to private and public enterprise and of wide benefit to society. Its services are solicited by customers and contractual partn...

More Information about "BioGenes - Gesellschaft für Biopolymere mbH" on BioPortfolio

We have published hundreds of BioGenes - Gesellschaft für Biopolymere mbH news stories on BioPortfolio along with dozens of BioGenes - Gesellschaft für Biopolymere mbH Clinical Trials and PubMed Articles about BioGenes - Gesellschaft für Biopolymere mbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioGenes - Gesellschaft für Biopolymere mbH Companies in our database. You can also find out about relevant BioGenes - Gesellschaft für Biopolymere mbH Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...


Corporate Database Quicklinks



Searches Linking to this Company Record